NasdaqGS - Nasdaq Real Time Price USD

MBX Biosciences, Inc. (MBX)

Compare
6.37
-0.60
(-8.61%)
At close: April 3 at 4:00:01 PM EDT
6.90
+0.53
+(8.32%)
Pre-Market: 5:45:53 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Operating Expense
68,194
68,194
35,311
25,161
Operating Income
-68,194
-68,194
-35,311
-25,161
Net Non Operating Interest Income Expense
6,272
6,272
2,748
-2
Other Income Expense
--
--
--
-972
Pretax Income
-61,922
-61,922
-32,563
-26,135
Net Income Common Stockholders
-61,922
-61,922
-32,563
-26,135
Diluted NI Available to Com Stockholders
-61,922
-61,922
-32,563
-26,135
Basic EPS
-5.82
--
-1.02
-0.82
Diluted EPS
-5.82
--
-1.02
-0.82
Basic Average Shares
10,642.95
--
31,853.70
31,853.70
Diluted Average Shares
10,642.95
--
31,853.70
31,853.70
Total Operating Income as Reported
-68,194
-68,194
-35,311
-25,161
Total Expenses
68,194
68,194
35,311
25,161
Net Income from Continuing & Discontinued Operation
-61,922
-61,922
-32,563
-26,135
Normalized Income
-61,922
-61,922
-32,563
-25,163
Interest Income
6,272
6,272
2,748
372
Interest Expense
--
--
--
374
Net Interest Income
6,272
6,272
2,748
-2
EBIT
-68,194
-68,194
-35,311
-25,761
EBITDA
-67,950
-67,950
-35,154
-25,705
Reconciled Depreciation
244
244
157
56
Net Income from Continuing Operation Net Minority Interest
-61,922
-61,922
-32,563
-26,135
Total Unusual Items Excluding Goodwill
--
--
--
-972
Total Unusual Items
--
--
--
-972
Normalized EBITDA
-67,950
-67,950
-35,154
-24,733
12/31/2022 - 9/13/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BCAX Bicara Therapeutics Inc.
11.83
-10.78%
 
ARTV Artiva Biotherapeutics, Inc.
2.5400
-11.19%
 
ZBIO Zenas BioPharma, Inc.
7.80
-7.47%
 
RAPP Rapport Therapeutics, Inc.
8.52
-14.46%
 
SEPN Septerna, Inc.
5.80
+5.55%
 
SER Serina Therapeutics, Inc.
5.49
+1.86%
 
MAZE Maze Therapeutics, Inc.
9.32
-10.13%
 
BNTC Benitec Biopharma Inc.
13.01
+3.67%
 
UPB Upstream Bio, Inc.
6.30
-2.93%
 
AARD Aardvark Therapeutics, Inc. Common Stock
8.69
-7.06%